Could breathing different oxygen levels ease chronic fatigue?

NCT ID NCT07317401

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a treatment called Intermittent Hypoxia-Hyperoxia Treatment (IHHT) for people with ME/CFS or long COVID. The therapy uses a mask to deliver short cycles of low and high oxygen, aiming to improve energy and reduce inflammation. 104 patients will be randomly assigned to receive either the real treatment or a placebo over eight weeks. Researchers will measure changes in fatigue, mental clarity, pain, and quality of life.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYALGIC ENCEPHALOMYELITIS/CHRONIC FATIGUE SYNDROME (ME/CFS) (ICD-10 G93.3) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Aarhus University

    Aarhus, Region Midt, 8200, Denmark

More trials for these conditions

Other studies related to the condition(s) this trial covers.